Osteochondral Defect Clinical Trial
Official title:
An Observational, Prospective, Multicentre Study of Patients With Outerbridge Grade III / IV Chondral and/or Osteochondral Defects of the Knee Treated With Nanofractured Autologous Matrix-induced Chondrogenesis
It is a prospective observational study of hospital cases. The objective is to determine the
decrease of lesion size and the regeneration of chondral tissue in femoral condyle cartilage
defect treated with NAMIC.
24 patients will be included
Background: The treatment of chondral lesions remains a challenge for orthopaedic surgeons.
They are most common in young active individuals and result in substantial impairment of
quality of life. The conventional joint treatment methods available to date, such as
Pridie-type perforations, microfractures using open or arthroscopic approaches and
mosaicoplasty are far from satisfactory. Cell-based therapies have also been tested in more
advanced research centres.
Nanofractured autologous matrix-induced chondrogenesis (NAMIC) is a simple, easily
reproducible implantation technique that can be performed in most hospitals to improve
clinical outcomes of patients with severe chondral lesions.
The present observational, multicentre study is based on the recently published NAMIC©
technique (Behrens_Bentin_06_2015 The Knee) that reports significant improvements over
previous techniques, especially regarding the reduction of rehabilitation period. Our main
aim is to confirm these results in a larger sample.
NAMIC is a matrix-guided minimally invasive stimulation of the subchondral bone marrow.
The present study will collect data on the usual medical practice when the NAMIC technique is
used to treat grade III or IV symptomatic focal cartilage lesions.
According to Chen 2011 JOR 2011, nanofracture achieves a uniform blood drainage and
pluripotential cell recruitment of the bone marrow through the depth of the 9mm perforations.
As observed by Eldracher AJS 2014, it also allows a faster recovery thanks to the minimal
aggression on the subchondral bone as the diameter of the drill holes is 1 mm.
According to the study published by Benthien JP, in Knee Surg Sports Traumatol Arthrosc 2011
Aug:19(8):1316-9, AMIC induces satisfactory chondrogenesis.
To date, the combination of nanofracture plus Cartimaix membrane has not been used in
patients in our environment.
Hypothesis: The NAMIC technique is useful for the treatment of chondral lesions of the knee.
Objectives:
Main: Determine the decrease of lesion size and the regeneration of chondral tissue in
femoral condyle cartilage defect treated with NAMIC.
Secondary: Assess the clinical results regarding pain, articular rigidity and function before
surgery and 12 months postoperatively.
Description of technique: After localization of the chondral lesion, the NAMIC technique
consists in: debridement of damaged tissue, removal of calcified cartilage with retention of
healthy surrounding vertical cartilage, minimally invasive subchondral bone marrow
stimulation, nanofracture (Nano FX, Arthrosurface, USA), and a posteriori protect the lesion,
stabilization of the clot, and facilitate stem cell adhesion and proliferation that migrate
from the bone marrow with a type I/ III collagen and elastine membrane (Cartimaix, Matricel,
Germany).
Nanofracture is a subchondral bone perforation procedure using a 1mm-thick needle, with a
depth of 9mm, 2mm apart , in a systemic spiral fashion in the whole periphery of the lesion,
using a specially-designed kit (Nano FX, Arthrosurface, USA). It allows a reproducible,
effective and minimally invasive stimulation of the subchondral bone. Nanofracture achieves a
uniform blood drainage and pluripotential cell recruitment of the bone marrow through the
depth of the 9mm perforations.
Subsequently, the lesion is traced with a template included in the kit (Cartimaix, Matricel,
Germany), and the membrane is cut to the adequate size, bearing in mind that it expands 10%
with hydration. The two-layer membrane is then implanted on the lesion, and left to be
hydrated by the blood from the stimulated area (Image 2). Cartimaix is a two-sided type I/
III collagen and elastine membrane that includes a smooth side (intraarticular) and a rough
side facing the cartilage. Finally, fibrin sealing is achieved (Tissel, Baxter, USA). This
technique can be combined with a graft in osteochondral injuries, but these are not
contemplated in the present study.
Variables:
Main variable: Amount of tissue repaired, calculating the filling area of the lesion.
Magnetic resonance will be used to determine the filling area at 12-month outpatient
follow-up visit.
The following information will be collected: a) size and localisation of the lesion; b)
alignment determined by telemetry; c) surgeries of cartilage or that may directly or
indirectly affect cartilage such as meniscectomy, osteotomy, microfracture, mosaicoplasty or
ligament repair.
A series of intraoperative pictures will be collected.
Secondary variables:
Pain: Visual analogue scale (VAS) Function and articular rigidity: KOOS scale, Tegner
Activity Scale during routine outpatients visits, at preoperative visit and at 12 months.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06216756 -
Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment of Osteochondral Lesions in the Knee
|
N/A | |
Completed |
NCT06078072 -
Biomaterials and Mesenchymal Stem/Stromal Cells in the Treatment of Knee Articular Surface Lesions
|
||
Terminated |
NCT00945399 -
Comparison of Microfracture Treatment and CARTIPATCH® Chondrocyte Graft Treatment in Femoral Condyle Lesions
|
Phase 3 | |
Recruiting |
NCT06225674 -
Clinical Investigation on the Outcome of Episealer Talus Post-operation for Treatment of Focal Osteochondral Defects
|
||
Completed |
NCT03385642 -
Follow-Up Study Evaluating the Long Term Outcome of ChondroMimetic in the Treatment of Osteochondral Defects in the Knee
|
||
Recruiting |
NCT05124613 -
The Impact of Covid-19 on Patients Waiting for Knee Surgery
|
||
Recruiting |
NCT04236492 -
Study Protocol to Evaluate Clinical and Imaging Results of Knee Fresh Osteochondral Allografts
|
||
Not yet recruiting |
NCT06462040 -
Evaluation of Clinical and Radiological Outcomes in Patients Undergoing Fixation of Osteochondral Fragments With Reasorbable Screws in the Knee Joint
|
||
Recruiting |
NCT03696394 -
A Study to Evaluate the Efficacy of BioCartilage® Micronized Cartilage Matrix in Microfracture Treatment of Osteochondral Defects
|
N/A | |
Recruiting |
NCT04364334 -
Knee Registry (Knieregister)
|
||
Completed |
NCT03452098 -
Post-Operative Rehabilitation of Knee Osteochondral Defect: A Case Series
|
||
Terminated |
NCT03036878 -
ReNu™ Marrow Stimulation Augmentation
|
N/A | |
Recruiting |
NCT03777735 -
Human Bone Graft for Fixation of Osteochondral Defects in the Knee Joint
|
||
Recruiting |
NCT03908931 -
Descriptive Study of the Reconstruction of Osteochondral Lesions of the Knee: Clinical and Imaging Results
|
N/A |